Significant progress is underway in pinpointing treatments and speeding up diagnosis of rare disease, thanks to digital trials and data-driven commercial strategy.
The use of artificial intelligence (AI) in the biopharma industry has the potential to revolutionise drug discovery and development, as well as improve patient care.
Inato has raised $20 million in early-stage financing to support the continued development of its clinical trial marketplace, which connects sponsors with its network of t